Hannah Brendan
Quince Therapeutics, Inc. · CBO
Hannah Brendan is listed in filings as CBO at Quince Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 23, 2026, including purchase activity. Recent filings connect the profile to Quince Therapeutics, Inc. (QNCX). The current snapshot covers public activity from Aug 21, 2024 to Jan 23, 2026. Reported amounts are shown as $1.1M to $23.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2.1k3.4k shares | BuyAug 20, 2024 | $0.60 | $18.82 | |
| $1.5k2.5k shares | BuyAug 20, 2024 | $0.61 | $18.82 | |
| $1.2k2.2k shares | BuyAug 19, 2024 | $0.58 | $18.82 |